AAAAAA

   
Results: 1-10 |
Results: 10
ANALYSIS OF COST OF ILLNESS OF LOW-BACK-P AIN
Authors: BOLTEN W KEMPELWAIBEL A PFORRINGER W
Citation: W. Bolten et al., ANALYSIS OF COST OF ILLNESS OF LOW-BACK-P AIN, Medizinische Klinik, 93(6), 1998, pp. 388-393
IMPACT OF ANTIINFLAMMATORY THERAPY ON PERIODONTAL-DISEASE IN RHEUMATOID-ARTHRITIS
Authors: GLEISSNER C WILLERSHAUSEN B KAESSER U BOLTEN W
Citation: C. Gleissner et al., IMPACT OF ANTIINFLAMMATORY THERAPY ON PERIODONTAL-DISEASE IN RHEUMATOID-ARTHRITIS, Journal of dental research, 77(5), 1998, pp. 1210-1210
EFFICACY AND SAFETY OF MELOXICAM IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: LEMMEL EM BOLTEN W BURGOSVARGAS R PLATT P NISSILA M SAHLBERG D BJORNEBOE O BAUMGARTNER H VALAT JP FRANCHIMONT P BLUHMKI E HANFT G DISTEL M
Citation: Em. Lemmel et al., EFFICACY AND SAFETY OF MELOXICAM IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Journal of rheumatology, 24(2), 1997, pp. 282-290
COEXISTING HYPERPARATHYROIDISM, RENAL OSTEODYSTROPHY AND PSORIATIC-ARTHRITIS
Authors: MARHOFFER W KAESSER U BAUER H FIEGEL P BALDAUF G BOLTEN W
Citation: W. Marhoffer et al., COEXISTING HYPERPARATHYROIDISM, RENAL OSTEODYSTROPHY AND PSORIATIC-ARTHRITIS, Rheumatology international, 17(2), 1997, pp. 79-82
CLINICAL-EVALUATION OF BONE METABOLISM IN PATIENTS WITH PSORIATIC-ARTHRITIS
Authors: MARHOFFER W STRACKE H MASOUD I SCHEJA M GRAEF V BOLTEN W FEDERLIN K
Citation: W. Marhoffer et al., CLINICAL-EVALUATION OF BONE METABOLISM IN PATIENTS WITH PSORIATIC-ARTHRITIS, Arthritis and rheumatism, 39(9), 1996, pp. 1379-1379
INTENSIFIED PHLEBOTOMY USING ERYTHROPOIET IN IN PRIMARY HEMOCHROMATOSIS - CASE-REPORT
Authors: STUBY U MULLERBRODMANN W BOLTEN W
Citation: U. Stuby et al., INTENSIFIED PHLEBOTOMY USING ERYTHROPOIET IN IN PRIMARY HEMOCHROMATOSIS - CASE-REPORT, Aktuelle Rheumatologie, 20(1), 1995, pp. 38-41
COMPARATIVE-STUDY OF TENIDAP, A CYTOKINE-MODULATING ANTIRHEUMATIC DRUG, AND DICLOFENAC IN RHEUMATOID-ARTHRITIS - A 24-WEEK ANALYSIS OF A 1-YEAR CLINICAL-TRIAL
Authors: WYLIE G APPELBOOM T BOLTEN W BREEDVELD FC FEELY J LEEMING MRG LELOET X MANTHORPE R MARCOLONGO R SMOLEN J
Citation: G. Wylie et al., COMPARATIVE-STUDY OF TENIDAP, A CYTOKINE-MODULATING ANTIRHEUMATIC DRUG, AND DICLOFENAC IN RHEUMATOID-ARTHRITIS - A 24-WEEK ANALYSIS OF A 1-YEAR CLINICAL-TRIAL, British journal of rheumatology, 34(6), 1995, pp. 554-563
EVIDENCE OF IMPAIRED CARTILAGE BONE TURNOVER IN PATIENTS WITH ACTIVE ANKYLOSING-SPONDYLITIS
Authors: MARHOFFER W STRACKE H MASOUD I SCHEJA M GRAEF V BOLTEN W FEDERLIN K
Citation: W. Marhoffer et al., EVIDENCE OF IMPAIRED CARTILAGE BONE TURNOVER IN PATIENTS WITH ACTIVE ANKYLOSING-SPONDYLITIS, Annals of the Rheumatic Diseases, 54(7), 1995, pp. 556-559
THE PHARMACOKINETICS, PHARMACODYNAMICS AND COMPARATIVE EFFICACY OF FLURBIPROFEN LAT
Authors: BOLTEN W
Citation: W. Bolten, THE PHARMACOKINETICS, PHARMACODYNAMICS AND COMPARATIVE EFFICACY OF FLURBIPROFEN LAT, British journal of clinical practice, 48(4), 1994, pp. 190-195
MANAGEMENT OF NSAR-ASSOCIATED GASTROPATHY
Authors: BOLTEN W HANTZSCHEL H HENGELS KJ STOCKBRUGGER R
Citation: W. Bolten et al., MANAGEMENT OF NSAR-ASSOCIATED GASTROPATHY, Aktuelle Rheumatologie, 16(5), 1991, pp. 171-174
Risultati: 1-10 |